Project Information

Project Overview

Category Key targets Issues to be resolved Goal
Self-sufficiency of NIP Vaccines DTaP Securing Acellular pertussis (aP) for the domestic supply of DTaP and combination vaccine Phase 2
Japanese Encephalitis Improving the vaccine safety by replacing the production process
Hepatitis A Recent outbreak and the need for stable supply of low-cost vaccine
Human Papilloma Virus Head and neck cancer indications in addition to cervical cancer
Vaccines of Global Unmet Need SFTS
  • Increase in outbreak
  • High mortality rate
  • Lack of treatment or prevention
Norovirus gastroenteritis
  • Frequent outbreaks in group facilities
  • No commercial vaccine available
Next-generation Tuberculosis
  • Ranked No. 1 mortality rate among OECD countries
  • Efficacy issue of BCG and need for booster vaccine for adults
Hand-Foot-and-Mouth Disease
  • Frequent outbreaks for infants and children
  • No commercial vaccine available
Universal Influenza
  • Vaccine mismatch and lack of efficacy of the seasonal vaccine
  • Need for cross-protective vaccines against drift and shift strains
Phase 1
Dengue Fever
  • Increased inflow of patients
  • Vaccine safety concern due to ADE (antibody-dependent enhancement)
Non clinical
Respiratory Syncytial Virus
  • High mortality rate for infants and toddlers
  • No commercial vaccine available
Vaccine platform technologies for emerging viral diseases Increase of pandemic outbreak and the need for the speedy delivery of vaccines Candidate Verification
Vaccine Platform Technology Novel Vaccine Adjuvant
  • Increase vaccine efficacy
  • Dose sparing effect
  • Applicable to a variety of vaccines
Vaccine Delivery System Platform for the speedy supply, non-invasive route of immunization, and augmenting vaccine efficacy